01 · Classification
How bromazolam works
Bromazolam is a novel synthetic triazolobenzodiazepine and central nervous system depressant. It is the bromo-substituted analog of alprazolam and is not approved for medical use by the U.S. Food and Drug Administration.
It acts as a high-potency positive allosteric modulator at GABA-A receptor complexes, enhancing inhibitory chloride-channel conductance and broadly depressing neural transmission across cortical and subcortical pathways.
Bromazolam is strongly lipophilic and has a significantly extended elimination half-life compared with pharmaceutical alprazolam. This can result in prolonged sedation and delayed emergence from peak intoxication.